Extending treatment to one year, the gap widens: about 4% greater weight loss in non-diabetics on semaglutide, and about 5.5% greater on tirzepatide. Some researchers suggest that behavioral differences such as motivation, adherence and engagement in lifestyle changes might help explain this gap
Common Gastrointestinal Side Effects Nausea affects most people starting semaglutide, typically beginning within the first few days of treatment
The same active ingredient is also sold as Ozempic, but that is a separate product authorised for type 2 diabetes, not for weight management
But some states, such as Michigan, have restricted eligibility for these medications to morbidly obesity patients rather than those who are overweight or obese
Your healthcare provider should check your thyroid function 6-8 weeks after starting or adjusting GLP-1 therapy and after significant weight loss